دورية أكاديمية
The judicious use of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy in the management of large brain metastases.
| العنوان: | The judicious use of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy in the management of large brain metastases. |
|---|---|
| المؤلفون: | Gutschenritter, T., Venur, V.A., Combs, S.E., Vellayappan, B., Patel, A.P., Foote, M., Redmond, K.J., Wang, T.J.C., Sahgal, A., Chao, S.T., Suh, J.H., Chang, E.L., Ellenbogen, R.G., Lo, S.S. |
| المصدر: | Cancers 13:70 (2021) |
| بيانات النشر: | Mdpi |
| سنة النشر: | 2021 |
| المجموعة: | PuSH - Publikationsserver des Helmholtz Zentrums München |
| مصطلحات موضوعية: | Hypofractionated Stereotactic Radiotherapy, Large Brain Metas-tases, Local Control, Radionecrosis, Stereotactic Radiosurgery |
| الوصف: | Brain metastases are the most common intracranial malignant tumor in adults and are a cause of significant morbidity and mortality for cancer patients. Large brain metastases, defined as tumors with a maximum dimension >2 cm, present a unique clinical challenge for the delivery of stereotactic radiosurgery (SRS) as patients often present with neurologic symptoms that require expeditious treatment that must also be balanced against the potential consequences of surgery and radiation therapy—namely, leptomeningeal disease (LMD) and radionecrosis (RN). Hypofractionated stereotactic radiotherapy (HSRT) and pre-operative SRS have emerged as novel treatment techniques to help improve local control rates and reduce rates of RN and LMD for this patient population commonly managed with post-operative SRS. Recent literature suggests that pre-operative SRS can potentially half the risk of LMD compared to post-operative SRS and that HSRT can improve risk of RN to less than 10% while improving local control when meeting the appropriate goals for biologically effective dose (BED) and dose-volume constraints. We recommend a 3-or 5-fraction regimen in lieu of SRS delivering 15 Gy or less for large metastases or resection cavities. We provide a table comparing the BED of commonly used SRS and HSRT regimens, and provide an algorithm to help guide the management of these challenging clinical scenarios. |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | English |
| تدمد: | 2072-6694 |
| العلاقة: | info:eu-repo/semantics/altIdentifier/pmid/33383817; info:eu-repo/semantics/altIdentifier/wos/WOS:000605791000001; info:eu-repo/semantics/altIdentifier/isbn/2072-6694; info:eu-repo/semantics/al; https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=60900Test; urn:isbn:2072-6694; urn:issn:2072-6694 |
| DOI: | 10.3390/cancers13010070 |
| الإتاحة: | https://doi.org/10.3390/cancers13010070Test https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=60900Test |
| حقوق: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.7B3CF81C |
| قاعدة البيانات: | BASE |
Full Text Finder | تدمد: | 20726694 |
|---|---|
| DOI: | 10.3390/cancers13010070 |